Treatment of Bacterial Endocarditis with Cephalosporin Derivatives in Penicillin-Allergic Patients
- 5 May 1966
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 274 (18) , 1002-1006
- https://doi.org/10.1056/nejm196605052741805
Abstract
BACTERIAL endocarditis was almost universally fatal before the advent of antibiotics.1 , 2 The poor prognosis radically improved in the 1940's with the availability of penicillin.3 To date, penicillin remains the single most effective antibiotic agent for the treatment of endocarditis due to gram-positive cocci.4 Unfortunately, approximately 2 per cent of the general population are allergic to penicillin.5 Furthermore, an estimated 18 per cent of adults with rheumatic or congenital heart lesions susceptible to endocarditis who have received regular prophylactic courses of penicillin may be allergic to the antibiotic.6 In the past, 3 principal methods of therapy were available to patients allergic . . .This publication has 19 references indexed in Scilit:
- CEPHALORIDINE TREATMENT OF BACTERIAL INFECTIONSThe Lancet Healthy Longevity, 1966
- Anaphylactoid Reaction to an Initial Dose of Sodium CephalothinJAMA, 1965
- CEPHALOTHINThe Lancet Healthy Longevity, 1964
- Laboratory Evaluation of a New Antibiotic--Cephaloridine (Ceporin)BMJ, 1964
- Penicillinase-resistant Penicillins and CephalosporinsBMJ, 1964
- Penicillin Hypersensitivity in Patients with Bacterial EndocarditisAnnals of Internal Medicine, 1964
- The New Penicillins and CephalosporinsAnnual Review of Medicine, 1964
- The treatment of endocarditisAmerican Heart Journal, 1963
- The Management of Bacterial EndocarditisArchives of internal medicine (1960), 1960
- Culstonian Lectures on MALIGNANT ENDOCARDITIS.The Lancet, 1885